Wongsirichot Phavit
Department of Chemical Engineering, The University of Manchester, Manchester, United Kingdom.
Crit Rev Biotechnol. 2025 Jun;45(4):887-903. doi: 10.1080/07388551.2024.2409112. Epub 2024 Oct 20.
The development and commercialization of bio-based and biodegradable polyhydroxyalkanoates (PHAs) biopolymers could be crucial for the transition toward a sustainable circular economy. However, despite potential traditional and novel applications in the packaging, textiles, agriculture, automotive, electronics, and biomedical industries, the commercialization of PHAs is limited by their current market competitiveness. This review provides the first critical assessment of the current pure culture pilot-scale PHA literature, which could be crucial in translating promising laboratory-scale developments into industrial-scale commercial PHA production. It will also complement reviews of mixed microbial cultures currently dominating pilot-scale PHA literature. Pure culture fermentations could provide advantages, such as ease of characterizing microbial producers' behavior, higher PHA productivities, and better alignment with existing PHA commercialization and industrial biotechnology approaches. Key aspects, including producer organisms, fermentation volumes and schemes, control schemes, optimization, and properties of the polymers produced, are discussed in-depth, to elucidate important trends, achievements, and knowledge gaps. Furthermore, specific ways for future pilot-scale studies to help address current PHA commercialization challenges are also identified. The insights, and recommendations provided will be extremely beneficial for the future development of PHA production, at both pilot and commercial scales, whilst also being beneficial to the production of other microbial polymers and industrial biotechnology as a whole.
生物基和可生物降解的聚羟基脂肪酸酯(PHA)生物聚合物的开发与商业化对于向可持续循环经济转型可能至关重要。然而,尽管PHA在包装、纺织、农业、汽车、电子和生物医学等行业有潜在的传统和新颖应用,但其商业化受到当前市场竞争力的限制。本综述首次对当前纯培养中试规模的PHA文献进行了批判性评估,这对于将有前景的实验室规模开发转化为工业规模的商业PHA生产可能至关重要。它还将补充目前主导中试规模PHA文献的混合微生物培养的综述。纯培养发酵可能具有优势,如易于表征微生物生产者的行为、更高的PHA生产率,以及与现有的PHA商业化和工业生物技术方法更好地契合。文中深入讨论了包括生产者生物体、发酵体积和方案、控制方案、优化以及所生产聚合物的性质等关键方面,以阐明重要趋势、成就和知识差距。此外,还确定了未来中试规模研究有助于应对当前PHA商业化挑战的具体方法。所提供的见解和建议将对PHA生产在中试和商业规模的未来发展极为有益,同时也有利于其他微生物聚合物的生产以及整个工业生物技术。